Effectiveness of a domestic absorbable membrane with enhanced shielding function for tissue regeneration in defect areas: a multicenter, comparative, and controlled clinical trial
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0008998
- Lead Sponsor
- dentium
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
1) Patients over 20 years of age who has completed the skeletal growth
2) Patients without disease or with a disease that is well controlled.
3) Patients who have more than one tooth missing and need the bone graft procedure for implant restoration
: Dentium implantation scheduled
4) Patients who voluntarily decided to participate in this clinical trial and agreed to the consent form of the subject in writing.
5) Patients who are willing to visit the clinic during a follow-up period and comply with a clinical trial plan
1) Patients who are pregnant
2) Patients who have metabolic diseases (uncontrolled diabetes, etc.)
3) Patients taking drugs that can affect bone metabolism – bisphosphonates, rhPTH, denosumab, etc.
4) Patients with uncontrolled gingivitis, periodontitis, or dental caries
5) Patients who have received radiation therapy in the treatment area
6) Patients with the hemorrhagic disease or need to take anticoagulants
7) Patients allergic to bone graft/implant materials
8) Smokers
9) Other improper patients who are thought to be inappropriate for participation due to the ethical issue, or because it may affect the results of the clinical trial
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the stability of the grafted bone material
- Secondary Outcome Measures
Name Time Method Comparative evaluation of bone augmentation through oral scanning